Allogeneic transplantation of recipients at high risk of graft versus host disease using CD34 positive cells selected from peripheral blood or bone marrow.

被引：0
|
作者：
Durrant, STS [1 ]
Hutchins, CJ [1 ]
James, K [1 ]
Seeley, G [1 ]
Taylor, K [1 ]
Lockwood, L [1 ]
机构：
[1] ROYAL BRISBANE HOSP,BONE MARROW TRANSPLANT UNIT,BRISBANE,QLD 4029,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4403 / 4403
页数：1
相关论文
共 50 条
  • [1] Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34(+) selected cells from peripheral blood
    UrbanoIspizua, A
    Rozman, C
    Martinez, C
    Marin, P
    Briones, J
    Rovira, M
    Feliz, P
    Viguria, MC
    Merino, A
    Sierra, J
    Mazzara, R
    Carreras, E
    Montserrat, E
    BLOOD, 1997, 89 (11) : 3967 - 3973
  • [2] CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation
    Butt, NM
    McGinnity, N
    Clark, RE
    LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1509 - 1513
  • [3] Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia
    Boyer, MW
    Gross, TG
    Loechelt, B
    Leemhuis, T
    Filipovich, A
    Harris, RE
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (11) : 890 - 895
  • [4] TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD AND BONE-MARROW CD34(+) CELLS AFTER IMMUNOSELECTION
    ARSENIEV, LH
    BAHRE, O
    KADAR, JG
    BERENSON, RJ
    BATTMER, K
    KUHL, J
    JACOBS, R
    SCHUBERT, J
    CASPER, J
    DIEDRICH, H
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 855 - 855
  • [5] Impact of CD34 cell dose on acute graft versus host disease after allogeneic bone marrow stem cell transplantation
    Damiani, D
    Sperotto, A
    Geromin, A
    Stocchi, R
    Fanin, R
    LEUKEMIA & LYMPHOMA, 2002, 43 (11) : 2245 - 2247
  • [6] Allogeneic bone marrow transplantation using CD34 enriched cells.
    Cornetta, K
    Mills, B
    Hanna, M
    Gharpure, V
    Hromas, R
    Abonour, R
    Robertson, M
    Broun, ER
    Cox, E
    Wyman, N
    Menke, C
    Baute, J
    Gonin, R
    Kunkel, L
    Oldham, F
    Srour, EF
    BLOOD, 1996, 88 (10) : 1920 - 1920
  • [7] Immune thyroiditis after transplantation of allogeneic CD34(+) selected peripheral blood cells
    Karthaus, M
    Gabrysiak, T
    Brabant, G
    Prahst, A
    Link, H
    Soudah, B
    Geissler, RG
    Diedrich, H
    Ganser, A
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 1997, 20 (08) : 697 - 699
  • [8] Supplementing allogeneic bone marrow with CD34 enriched peripheral blood cells.
    Burt, RK
    Oyama, Y
    Brush, M
    Rodriguez, J
    Traynor, AE
    BLOOD, 2001, 98 (11) : 412A - 413A
  • [9] COMBINED TRANSPLANTATION OF ALLOGENEIC BONE-MARROW AND CD34(+) BLOOD-CELLS
    LINK, H
    ARSENIEV, L
    BAHRE, O
    BERENSON, RJ
    BATTMER, K
    KADAR, JG
    JACOBS, R
    CASPER, J
    KUHL, J
    SCHUBERT, J
    DIEDRICH, H
    POLIWODA, H
    BLOOD, 1995, 86 (07) : 2500 - 2508
  • [10] Clinical results of bone marrow transplantation in combination with CD34(+) selected peripheral blood stem cells in high risk patients with leukaemia.
    Blau, IW
    Serr, A
    Schilz, A
    Schmetzer, B
    Herrmann, D
    Bender, M
    Bischoff, M
    Roemer, E
    Fauser, AA
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 131 - 131
12345